Showing results (81-90 of 626) with videos related to
Sort By:
Pageof 63
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2023
Splenectomy in epithelial ovarian cancer surgeryHoussein El Hajj, Domenico Ferraioli, Pierre Meus, et al.Frontiers in Oncology|March 28, 2024
BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challengesLaetitia Collet, Brunhilde Hanvic, Margherita Turinetto, et al.Frontiers in Oncology|March 14, 2022
The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 PathwaysMichael J Birrer, Keiichi Fujiwara, Ana Oaknin, et al.BMC Cancer|March 19, 2013
Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experienceAlice Levard, Olfa Derbel, Pierre Méeus, et al.Cancer Treatment Reviews|July 31, 2021
PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectationsHélène Vanacker, Philipp Harter, Sana Intidhar Labidi-Galy, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 16, 2017
High proportion of abnormal pap smear tests and cervical dysplasia in women with cystic fibrosisChristine Rousset-Jablonski, Quitterie Reynaud, Raphaëlle Nove-Josserand, et al.ESMO Open|December 14, 2020
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussionSusana Banerjee, Antonio Gonzalez-Martin, Philipp Harter, et al.Nature Reviews. Disease Primers|December 10, 2021
Endometrial cancerVicky Makker, Helen MacKay, Isabelle Ray-Coquard, et al.Expert Opinion on Emerging Drugs|March 16, 2007
Emerging drugs for the treatment of soft tissue sarcomasPhilippe A Cassier, Armelle Dufresne, Jérôme Fayette, et al.Pageof 63